Australia markets closed

Spectral Medical Inc. (EDT.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
0.50000.0000 (0.00%)
At close: 03:59PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 139.70M
Enterprise value 146.89M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)80.30
Price/book (mrq)N/A
Enterprise value/revenue 84.61
Enterprise value/EBITDA -9.33

Trading information

Stock price history

Beta (5Y monthly) 0.91
52-week change 351.52%
S&P500 52-week change 329.31%
52-week high 30.6700
52-week low 30.2250
50-day moving average 30.4513
200-day moving average 30.4279

Share statistics

Avg vol (3-month) 365.69k
Avg vol (10-day) 3121.26k
Shares outstanding 5279.39M
Implied shares outstanding 6279.39M
Float 8190.13M
% held by insiders 120.50%
% held by institutions 113.14%
Shares short (30 Apr 2024) 4239.06k
Short ratio (30 Apr 2024) 46.47
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.09%
Shares short (prior month 28 Mar 2024) 4263.94k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 419 Dec 2011
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-319.31%

Management effectiveness

Return on assets (ttm)-103.96%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)1.74M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)26.00%
Gross profit (ttm)N/A
EBITDA -11.41M
Net income avi to common (ttm)-18.57M
Diluted EPS (ttm)-0.0600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.07M
Total cash per share (mrq)0.01
Total debt (mrq)9.26M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.36
Book value per share (mrq)-0.07

Cash flow statement

Operating cash flow (ttm)-8.45M
Levered free cash flow (ttm)1.62M